New Drugs and Interventional Strategies for the Management of Hypertension.
Curr Pharm Des
; 27(11): 1396-1406, 2021.
Article
em En
| MEDLINE
| ID: mdl-33155904
ABSTRACT
Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide with significant clinical and economic implications. The field of antihypertensive treatment already numbers numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve a tailored approach to the individual patient, with genetic modulation playing a key role.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Preparações Farmacêuticas
/
Hipertensão
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article